Marseilles, France

Nicolas Levy



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Marseille Cedex, FR (2013)
  • Marseilles, FR (2013 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nicolas Levy: Innovator in Anti-HIV Treatments and Genetic Analysis

Introduction

Nicolas Levy is a prominent inventor based in Marseilles, France. He has made significant contributions to the fields of medical treatment and genetic analysis, holding a total of 5 patents. His work focuses on innovative solutions for complex health issues, particularly in the context of HIV treatment and genetic disorders.

Latest Patents

One of Levy's latest patents is a composition and methods used during anti-HIV treatment. This invention relates to a composition that combines an anti-HIV treatment with a treatment for the side effects of said anti-HIV treatment in HIV-infected patients. This invention is particularly useful in addressing side effects caused by certain anti-HIV treatments, such as premature aging and lipodystrophy, which can result from protease inhibitors or reverse transcriptase inhibitors. The composition includes at least one hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, at least one farnesyl-pyrophosphate synthase inhibitor, and at least one anti-HIV agent. The process for treating an HIV-infected patient involves the administration of a mixture containing these inhibitors and an anti-HIV agent, which can be administered concomitantly, successively, or alternatively.

Another significant patent by Levy is a method for analyzing D4Z4 tandem repeat arrays of nucleic acid and a kit for this purpose. This invention pertains to a method for analyzing in vitro D4Z4 tandem repeat arrays of nucleic acid found on chromosomes, specifically Human chromosomes 4 and 10. The method is designed to determine the number of D4Z4 repeat units in these arrays and is based on stretching nucleic acid through Molecular Combing. It also includes the use of specially designed nucleic acid probes. This invention is crucial for diagnosing facioscapulohumeral muscular dystrophy (FSHD) and identifying biochemical events in regions containing such tandem repeat arrays.

Career Highlights

Nicolas Levy has worked with notable institutions such as Université d'Aix-Marseille and Assistance Publique Hôpitaux de Marseille. His career reflects a commitment to advancing medical science and improving patient outcomes through innovative research and development.

Collaborations

Levy has collaborated with esteemed colleagues, including Pierre Cau and Carlos Lopez-Otin. These partnerships have contributed to the depth

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…